These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9163848

  • 1. Abnormal lipid metabolism and renal disorders.
    Saito T.
    Tohoku J Exp Med; 1997 Mar; 181(3):321-37. PubMed ID: 9163848
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF, Lin CC, Chen JY, Yang AH, Shiao MS, Kao JT, Yang WC.
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [Abstract] [Full Text] [Related]

  • 3. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.
    Oikawa S, Suzuki N, Sakuma E, Saito T, Namai K, Kotake H, Fujii Y, Toyota T.
    Am J Kidney Dis; 1991 Nov; 18(5):553-8. PubMed ID: 1951334
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature.
    Saito T, Sato H, Oikawa S, Kudo K, Kurihara I, Nakayama K, Abe K, Yoshinaga K, Sakaguchi H.
    Am J Nephrol; 1993 Nov; 13(1):64-8. PubMed ID: 8322843
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney.
    Miyata T, Sugiyama S, Nangaku M, Suzuki D, Uragami K, Inagi R, Sakai H, Kurokawa K.
    J Am Soc Nephrol; 1999 Jul; 10(7):1590-5. PubMed ID: 10405216
    [Abstract] [Full Text] [Related]

  • 6. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
    Arai T, Yamashita S, Yamane M, Manabe N, Matsuzaki T, Kiriyama K, Kanayama Y, Himeno S, Matsuzawa Y.
    Atherosclerosis; 2003 Aug; 169(2):293-9. PubMed ID: 12921981
    [Abstract] [Full Text] [Related]

  • 7. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
    Sakatsume M, Kadomura M, Sakata I, Imai N, Kondo D, Osawa Y, Shimada H, Ueno M, Miida T, Nishi S, Arakawa M, Gejyo F.
    Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
    Karube M, Nakabayashi K, Fujioka Y, Yoshihara K, Yamada A, Matsunaga A, Saito T.
    Clin Exp Nephrol; 2007 Jun; 11(2):174-179. PubMed ID: 17593519
    [Abstract] [Full Text] [Related]

  • 9. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T, Ishigaki Y, Oikawa S, Yamamoto TT.
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.
    Saito T, Oikawa S, Sato H, Sato T, Ito S, Sasaki J.
    Kidney Int Suppl; 1999 Jul; 71():S37-41. PubMed ID: 10412734
    [Abstract] [Full Text] [Related]

  • 11. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
    Ellis D, Orchard TJ, Lombardozzi S, Yunis EJ, McCauley J, Agostini R, Diamond JR.
    J Am Soc Nephrol; 1995 Oct; 6(4):1170-7. PubMed ID: 8589283
    [Abstract] [Full Text] [Related]

  • 12. Lipids and the progression of renal disease.
    Keane WF, O'Donnell MP, Kasiske BL, Schmitz PG.
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E-related glomerular disorders.
    Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E.
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [Abstract] [Full Text] [Related]

  • 14. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T, Matsunaga A, Oikawa S.
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A case of lipoprotein glomerulopathy successfully treated with probucol.
    Amenomori M, Haneda M, Morikawa J, Nishigaki I, Maeda S, Hidaka H, Kikkawa R, Shigeta Y.
    Nephron; 1994 Feb; 67(1):109-13. PubMed ID: 8052351
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.